Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Re medical vs business buckhenry

<< Previous

Bullboard Posts

Next >>

Comment by canadafanon Sep 02, 2022 7:48pm

224 Views

Post# 34939572

RE:RE:RE:RE:RE:RE:Re medical vs business buckhenry

d like to add yet another, seldom discussed side on ONC Pelareorep. Point: There are a handful of trials we have named & talked about repeatedly. How about the 100 or so people ( patients in trials), who wake up every day with hope. hope of progress from Pela & other combo treatments. Yet, perhaps at bed time sleep in fear of treatment failure. Do they own shares in Onc? Maybe, maybe not. Their “lottery” is not measured in SP, Market cap, daily trading volume. They no doubt along with their families hope & pray for success. THAT is an investment. let that sink in a while …

<< Previous

Bullboard Posts

Next >>

10 common investing mistakes to avoid